Association of Triglyceride and Glucose Index with Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus Patients

This study is an analytical observational study with a cross-sectional approach.The sample for this study was T2DM patients at the diabetes outpatient ABSTRACT Introduction: Non-alcoholic fatty liver disease (NAFLD) is significantly linked to obesity, insulin resistance (IR), metabolic syndrome, and type 2 diabetes (T2DM).There isn't a single biomarker used to diagnose NAFLD.Objectives: Analyzing the association between triglyceride and glucose index (TyG) with NAFLD in T2DM.Methods: This cross-sectional study aimed to assess the efficacy of TyG as a potential NAFLD biomarker.The study was conducted on 103 diabetes outpatient clinics at the Dr. Soetomo General Academic Hospital from August to October 2023.Sixty-seven subjects experienced steatosis, while those who did not experience steatosis were 36.The statistical analysis used in this study is binary logistic regression with p <0.05.Results: The receiver operating characteristic curves (ROC) analysis showed a TyG cut-off value of 9.334 (AUC = 0.660).Analysis of the risk of TyG on the incidence of steatosis was carried out using binary logistic regression.The results showed that TyG was a significant risk factor for steatosis.Patients with a TyG value above 9.334 risk developing steatosis 3.567 times greater than patients with a TyG value below 9.334 (OR 95% = 1.373 -9.270, p = 0.009).Conclusion: A significant association between TyG and NAFLD in T2DM patients, which the TyG index may be a more effective, valuable, and uncomplicated measure for detecting and controlling NAFLD.

Authors

Publication Details

Journal
Pharmacognosy Journal
Published
2024-11-01
DOI
https://doi.org/10.5530/pj.2024.16.174
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of Triglyceride and Glucose Index with Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus Patients

Soebagijo Adi Soelistijo, Titong Sugihartono, Sony Wibisono Mudjanarko, Febri Kurniawati
Pharmacognosy Journal
Liver Disease Diagnosis and Treatment
article

Association of Triglyceride and Glucose Index with Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus Patients

Soebagijo Adi Soelistijo, Titong Sugihartono, Sony Wibisono Mudjanarko, Febri Kurniawati
article en

Abstract

This study is an analytical observational study with a cross-sectional approach.The sample for this study was T2DM patients at the diabetes outpatient ABSTRACT Introduction: Non-alcoholic fatty liver disease (NAFLD) is significantly linked to obesity, insulin resistance (IR), metabolic syndrome, and type 2 diabetes (T2DM).There isn't a single biomarker used to diagnose NAFLD.Objectives: Analyzing the association between triglyceride and glucose index (TyG) with NAFLD in T2DM.Methods: This cross-sectional study aimed to assess the efficacy of TyG as a potential NAFLD biomarker.The study was conducted on 103 diabetes outpatient clinics at the Dr. Soetomo General Academic Hospital from August to October 2023.Sixty-seven subjects experienced steatosis, while those who did not experience steatosis were 36.The statistical analysis used in this study is binary logistic regression with p <0.05.Results: The receiver operating characteristic curves (ROC) analysis showed a TyG cut-off value of 9.334 (AUC = 0.660).Analysis of the risk of TyG on the incidence of steatosis was carried out using binary logistic regression.The results showed that TyG was a significant risk factor for steatosis.Patients with a TyG value above 9.334 risk developing steatosis 3.567 times greater than patients with a TyG value below 9.334 (OR 95% = 1.373 -9.270, p = 0.009).Conclusion: A significant association between TyG and NAFLD in T2DM patients, which the TyG index may be a more effective, valuable, and uncomplicated measure for detecting and controlling NAFLD.

Pharmacognosy JournalVol. 16(5)
Good health and well-being
Openalex Percentile: Top 70%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.